References
- Burkhoff D , SayerG, DoshiD, UrielN. Hemodynamics of mechanical circulatory support. J. Am. Coll. Cardiol., 66(23), 2663–2674 (2015).
- Esposito ML , KapurNK. Acute mechanical circulatory support for cardiogenic shock: the “door to support” time. F1000Res, 6, 737 (2017).
- O’Neill WW , KleimanNS, MosesJet al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation, 126(14), 1717–1727 (2012).
- Basir MB , KapurNK, PatelKet al. Improved outcomes associated with the use of shock protocols: updates from the national cardiogenic shock initiative. Catheter Cardiovasc. Interv., 93(7), 1173–1183 (2019).
- Tehrani BN , TruesdellAG, SherwoodMWet al. Standardized team-based care for cardiogenic shock. J. Am. Coll. Cardiol., 73(13), 1659–1669 (2019).
- Sintek MA , GdowskiM, LindmanBRet al. Intra-aortic balloon counterpulsation in patients with chronic heart failure and cardiogenic shock: clinical response and predictors of stabilization. J. Card. Fail., 21(11), 868–876 (2015).
- Annamalai SK , BuitenL, EspositoMLet al. Acute hemodynamic effects of intra-aortic balloon counterpulsation pumps in advanced heart failure. J. Card. Fail., 23(8), 606–614 (2017).
- Fried JA , NairA, TakedaKet al. Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock. J. Heart Lung Transplant., 37(11), 1313–1321 (2018).
- Kapur NK , ParuchuriV, MajithiaAet al. Hemodynamic effects of standard versus larger-capacity intraaortic balloon counterpulsation pumps. J. Invasive Cardiol., 27(4), 182–188 (2015).
- den Uil CA , Van MieghemNM, BastosMBet al. Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial. EuroIntervention, 15(7), 586–593 (2019).
- Bhimaraj A , AgrawalT, DuranAet al. Percutaneous left axillary artery placement of intra-aortic balloon pump in advanced heart failure patients. JACC Heart Fail., 8(4), 313–323 (2020).
- Bastos MB , van WiechenMP, Van MieghemNM. PulseCath iVAC2L: next-generation pulsatile mechanical circulatory support. Future Cardiol., 16(2), 103–112 (2020).
- Samol A , SchmidtS, ZeyseM, WiemerM, LuaniB. High-risk PCI under support of a pulsatile left ventricular assist device – First German experience with the iVAC2L system. Int. J. Cardiol., 297, 30–35 (2019).
- Abraham WT , AggarwalS, PrabhuSDet al. Ambulatory extra-aortic counterpulsation in patients with moderate to severe chronic heart failure. JACC Heart Fail., 2(5), 526–533 (2014).
- Uriel N , JeevanandamV, ImamuraTet al. Clinical Outcomes and Quality of Life With an Ambulatory Counterpulsation Pump in Advanced Heart Failure Patients: Results of the Multicenter Feasibility Trial. Circ. Heart Fail., 13(4), e006666 (2020).
- Vora AN , SchuylerJones W, DeVore AD, EbnerA, CliftonW, PatelMR. First-in-human experience with Aortix intraaortic pump. Catheter Cardiovasc. Interv., 93(3), 428–433 (2019).
- Annamalai SK , EspositoML, ReyeltLAet al. Abdominal positioning of the Next-Generation Intra-Aortic Fluid Entrainment Pump (Aortix) improves cardiac output in a Swine Model of heart failure. Circ. Heart Fail., 11(8), e005115 (2018).
- Jeevanandam V , Song T, OnsagerDet al. The first-in-human experience with a minimally invasive, ambulatory, counterpulsation heart assist system for advanced congestive heart failure. J. Heart Lung Transplant. 37(1), 1–6 (2018).
- Smith EJ , ReitanO, KeebleT, DixonK, RothmanMT. A first-in-man study of the Reitan catheter pump for circulatory support in patients undergoing high-risk percutaneous coronary intervention. Catheter Cardiovasc. Interv., 73(7), 859–865 (2009).
- Shabari FR , GeorgeJ, CuchiaraMPet al. Improved hemodynamics with a novel miniaturized intra-aortic axial flow pump in a porcine model of acute left ventricular dysfunction. ASAIO J., 59(3), 240–245 (2013).
- del Rio C , CliftonW, HeuringJet al. Aortix, a novel catheter-based intra-vascular assist device, provides cardio-renal support while improving ventriculo-arterial coupling and myocardial demand in sheep with induced chronic ischemic heart failure. J. Am. Coll. Cardiol., 65(Suppl. 10), A800 (2015).
- Reitan O , SteenS, OhlinH. Hemodynamic effects of a new percutaneous circulatory support device in a left ventricular failure model. ASAIO J., 49(6), 731–736 (2003).
- Keeble TR , KaramasisGV, RothmanMTet al. Percutaneous haemodynamic and renal support in patients presenting with decompensated heart failure: a multi-centre efficacy study using the Reitan Catheter Pump (RCP). Int. J. Cardiol., 275, 53–58 (2019).
- Reitan O , OhlinH, PeterzénB, GranfeldtH, SteenS, EmanuelssonH. Initial tests with a new cardiac assist device. ASAIO J., 45(4), 317–321 (1999).
- Second Heart Assist [Website]. https://secondheartinc.com
- First-in-human experience with Second Heart Assist aortic stent circulatory assist pump. Presented at: The Heart Failure Society of American Annual Scientific Meeting.PA, USA (2019).
- Rosenblum H , KapurNK, AbrahamWT, UdelsonJ, ItkinM, UrielN, VoorsAA, BurkhoffD. Conceptual considerations for device-based therapy in acute decompensated heart failure: DRI(2)P(2)S. Circ. Heart Hail., 13(4), e006731 (2020).
- Kapur NK , ReyeltL, CrowleyPet al. Intermittent occlusion of the superior vena cava reduces cardiac filling pressures in preclinical models of heart failure. J. Cardiovasc. Trans. Res., 13(2), 151–157 (2020).